Evidence map›Paper›PMID 25866686›Full record

ArticleCase reports in infectious diseases2015

Pseudomonas aeruginosa Acquisition in Cystic Fibrosis Patients in Context of Otorhinolaryngological Surgery or Dentist Attendance: Case Series and Discussion of Preventive Concepts.

Jochen G Mainz, Andrea Gerber, Michael Lorenz, Ruth Michl, Julia Hentschel, Anika Nader, James F Beck, Mathias W Pletz, Andreas H Mueller

Open access · goldAbstract read
In one paragraph

Article in Case reports in infectious diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Long-term control ofFrontiers in oral health · 2026
    Article
  4. Review
  5. Infectious medicine · 2023
    Review
  6. [Management of Primary Ciliary Dyskinesia].Pneumologie (Stuttgart, Germany) · 2020
    Review
  7. Review
  8. Article
  9. Dental treatment for people with cystic fibrosis.European archives of paediatric dentistry : official journal of the European Academy of Paediatric Dentistry · 2016
    Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Jochen G MainzCystic Fibrosis Center, Pediatric Pneumology, Jena University Hospital, 07740 Jena, Germany.
Andrea GerberCystic Fibrosis Center, Pediatric Pneumology, Jena University Hospital, 07740 Jena, Germany.
Michael LorenzCystic Fibrosis Center, Pediatric Pneumology, Jena University Hospital, 07740 Jena, Germany.
Ruth MichlCystic Fibrosis Center, Pediatric Pneumology, Jena University Hospital, 07740 Jena, Germany.
Julia HentschelCystic Fibrosis Center, Pediatric Pneumology, Jena University Hospital, 07740 Jena, Germany.
Anika NaderCystic Fibrosis Center, Pediatric Pneumology, Jena University Hospital, 07740 Jena, Germany.
James F BeckCystic Fibrosis Center, Pediatric Pneumology, Jena University Hospital, 07740 Jena, Germany.
Mathias W PletzCenter for Infectious Diseases and Infection Control, Jena University Hospital, 07740 Jena, Germany.
Andreas H MuellerDepartment of Otorhinolaryngology/Plastic Surgery, SRH Wald-Klinikum, 07548 Gera, Germany.
Jena University Hospital · DESRH Wald-Klinikum Gera · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction. P. aeruginosa is the primary cause for pulmonary destruction and premature death in cystic fibrosis (CF). Therefore, prevention of airway colonization with the pathogen, ubiquitously present in water, is essential. Infection of CF patients with P. aeruginosa after dentist treatment was proven and dental unit waterlines were identified as source, suggesting prophylactic measures. For their almost regular sinonasal involvement, CF patients often require otorhinolaryngological (ORL) attendance. Despite some fields around ORL-procedures with comparable risk for acquisition of P. aeruginosa, such CF cases have not yet been reported. We present four CF patients, who primarily acquired P. aeruginosa around ORL surgery, and one around dentist treatment. Additionally, we discuss risks and preventive strategies for CF patients undergoing ORL-treatment. Perils include contact to pathogen-carriers in waiting rooms, instrumentation, suction, drilling, and flushing fluid, when droplets containing pathogens can be nebulized. Postsurgery mucosal damage and debridement impair sinonasal mucociliary clearance, facilitating pathogen proliferation and infestation. Therefore, sinonasal surgery and dentist treatment of CF patients without chronic P. aeruginosa colonization must be linked to repeated microbiological assessment. Further studies must elaborate whether all CF patients undergoing ORL-surgery require antipseudomonal prophylaxis, including nasal lavages containing antibiotics. Altogether, this underestimated risk requires structured prevention protocols.

Identifiers

PMID25866686
PMCPMC4381717
OpenAlexW2073204549

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.